title: Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury.
abstract: BACKGROUND
  Ischaemia reperfusion injury can lead to kidney dysfunction or failure. Ischaemic preconditioning is a short period of deprivation of blood supply to particular organs or tissue, followed by a period of reperfusion. It has the potential to protect kidneys from ischaemia reperfusion injury.
  
  
  OBJECTIVE
  This review aimed to look at the benefits and harms of local and remote ischaemic preconditioning to reduce ischaemia and reperfusion injury among people with renal ischaemia reperfusion injury.
  
  
  METHODS
  We searched Cochrane Kidney and Transplant's Specialised Register to 5 August 2016 through contact with the Information Specialist using search terms relevant to this review.
  
  
  METHODS
  We included all randomised controlled trials measuring kidney function and the role of ischaemic preconditioning in patients undergoing a surgical intervention that induces kidney injury. Kidney transplantation studies were excluded.
  
  
  METHODS
  Studies were assessed for eligibility and quality; data were extracted by two independent authors. We collected basic study characteristics: type of surgery, remote ischaemic preconditioning protocol, type of anaesthesia. We collected primary outcome measurements: serum creatinine and adverse effects to remote ischaemic preconditioning and secondary outcome measurements: acute kidney injury, need for dialysis, neutrophil gelatinase-associated lipocalin, hospital stay and mortality. Summary estimates of effect were obtained using a random-effects model, and results were expressed as risk ratios (RR) and their 95% confidence intervals (CI) for dichotomous outcomes, and mean difference (MD) and 95% CI for continuous outcomes.
  
  
  RESULTS
  We included 28 studies which randomised a total of 6851 patients. Risk of bias assessment indicated unclear to low risk of bias for most studies. For consistency regarding the direction of effects, continuous outcomes with negative values, and dichotomous outcomes with values less than one favour remote ischaemic preconditioning. Based on high quality evidence, remote ischaemic preconditioning made little or no difference to the reduction of serum creatinine levels at postoperative days one (14 studies, 1022 participants: MD -0.02 mg/dL, 95% CI -0.05 to 0.02; I2= 21%), two (9 studies, 770 participants: MD -0.04 mg/dL, 95% CI -0.09 to 0.02; I2= 31%), and three (6 studies, 417 participants: MD -0.05 mg/dL, 95% CI -0.19 to 0.10; I2= 68%) compared to control.Serious adverse events occurred in four patients receiving remote ischaemic preconditioning by iliac clamping. It is uncertain whether remote ischaemic preconditioning by cuff inflation leads to increased adverse effects compared to control because the certainty of the evidence is low (15 studies, 3993 participants: RR 3.47, 95% CI 0.55 to 21.76; I2= 0%); only two of 15 studies reported any adverse effects (6/1999 in the remote ischaemic preconditioning group and 1/1994 in the control group), the remaining 13 studies stated no adverse effects were observed in either group.Compared to control, remote ischaemic preconditioning made little or no difference to the need for dialysis (13 studies, 2417 participants: RR 0.85, 95% CI 0.37 to 1.94; I2= 60%; moderate quality evidence), length of hospital stay (8 studies, 920 participants: MD 0.17 days, 95% CI -0.46 to 0.80; I2= 49%, high quality evidence), or all-cause mortality (24 studies, 4931 participants: RR 0.86, 95% CI 0.54 to 1.37; I2= 0%, high quality evidence).Remote ischaemic preconditioning may have slightly improved the incidence of acute kidney injury using either the AKIN (8 studies, 2364 participants: RR 0.76, 95% CI 0.57 to 1.00; I2= 61%, high quality evidence) or RIFLE criteria (3 studies, 1586 participants: RR 0.91, 95% CI 0.75 to 1.12; I2= 0%, moderate quality evidence).
  
  
  CONCLUSIONS
  Remote ischaemic preconditioning by cuff inflation appears to be a safe method, and probably leads to little or no difference in serum creatinine, adverse effects, need for dialysis, length of hospital stay, death and in the incidence of acute kidney injury. Overall we had moderate-high certainty evidence however the available data does not confirm the efficacy of remote ischaemic preconditioning in reducing renal ischaemia reperfusion injury in patients undergoing major cardiac and vascular surgery in which renal ischaemia reperfusion injury may occur.
authors.affiliation: Department of Surgery, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, Gelderland, Netherlands, 6525 GA.
authors.forename: Theo P
authors.initials: TP
authors.lastname: Menting
authors.affiliation: Department of Surgery, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, Gelderland, Netherlands, 6525 GA.
authors.forename: Kimberley E
authors.initials: KE
authors.lastname: Wever
authors.affiliation: Department of Surgery, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, Gelderland, Netherlands, 6525 GA.
authors.forename: Denise Md
authors.initials: DM
authors.lastname: Ozdemir-van Brunschot
authors.affiliation: Department of Surgery, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, Gelderland, Netherlands, 6525 GA.
authors.forename: Daan Ja
authors.initials: DJ
authors.lastname: Van der Vliet
authors.affiliation: Department of Operating Rooms, Radboud University Nijmegen Medical Centre, Hp 630, route 631, PO Box 9101, Nijmegen, Netherlands, 6500 HB.
authors.forename: Maroeska M
authors.initials: MM
authors.lastname: Rovers
authors.affiliation: Department of Surgery, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, Gelderland, Netherlands, 6525 GA.
authors.forename: Michiel C
authors.initials: MC
authors.lastname: Warle
mesh_terms: D003404:Creatinine / Q000097:blood; D006801:Humans; D019194:Ischemic Preconditioning / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D007668:Kidney / Q000098:blood supply*; D007674:Kidney Diseases / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D015427:Reperfusion Injury / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D003404:Creatinine